COVAC1 Phase 2a Expanded Safety and Immunogenicity Study of a Self-Amplifying RNA Vaccine Against SARS-CoV-2 (2022)
Attributed to:
saRNA SARS-CoV-2 vaccine
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.4231236
Publication URI: http://dx.doi.org/10.2139/ssrn.4231236
Type: Journal Article/Review
Parent Publication: SSRN Electronic Journal